ARTICLES BY THIS AUTHOR
- 11/10/2021
Camber unveils generic Samsca
Tolvaptan tablets are used to treat hyponatremia, or low levels of sodium in the blood, in people with heart failure and certain hormonal imbalances. - 11/10/2021
Pharmacy orgs: Lack of DIR fee reform in budget reconciliation bill affects seniors’ drug savings
NACDS, and NCPA point out how the failure to include pharmacy DIR fee reform in the budget reconciliation bill will deprive Medicare beneficiaries of reduced cost sharing for prescription drugs. - 11/10/2021
CVS Health partners with disability community on equitable healthcare access
CVS Health said its agreement to pursue policy solutions in collaboration with the disability community will help protect access to affordable health plan programs that apply equally to all members. - 11/9/2021
Pfizer, BioNTech asks FDA to authorize COVID-19 boosters for all adults
Pfizer and BioNTech is reportedly seeking emergency use authorization from the Food and Drug Administration for a COVID-19 vaccine booster for all individuals aged 18 years old and older. - 11/8/2021
Walgreens’ chief medical officer departs to join MDisrupt
Chet Robson, former chief clinical officer at Walgreens, will spearhead the advancement of MDisrupt’s Digital Health Standards Platform to enable the assessment of healthcare technologies based on real-world clinical performance. - 11/8/2021
FDA has resumed normal review pace for biosimilars, generics
The Food and Drug Administration is meeting with biosimilar developers for biosimilars for 46 reference products. - 11/8/2021
HRG marks 41-year anniversary with Growth Summit
HRG reached a 40-plus milestone, inviting clients and vendor partners to celebrate at its Growth Summit. - 11/8/2021
Cardinal Health reports revenue growth in Q1
Cardinal Health reported Q1 revenue of $44 billion, an increase of 13% from the same period last year. - 11/8/2021
ANI closes $75M public offering of common stock
A total of 1,500,000 shares of ANI's common stock were sold at a public offering price of $50 per share. - 11/8/2021
Lannett announces cost saving restructuring plan
The plan includes discontinuing future development programs targeting liquid generic medications.